Rhythm Pharmaceuticals (RYTM) Assets (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Assets of $442.3 million for Q1 2026, up 14.39% year-over-year from $386.7 million in Q1 2025, and down 7.89% quarter-over-quarter from $480.2 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Assets (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Assets for 11 consecutive years, with $442.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 14.39% year-over-year to $442.3 million; the TTM figure through Mar 2026 stood at $442.3 million (up 14.39% YoY), while the FY2025 annual figure was $480.2 million, up 22.41% from the prior year.
- Assets retreated to $442.3 million in Q1 2026 per RYTM's latest filing, from $480.2 million in the prior quarter.
- Across five years, Assets topped out at $506.9 million in Q3 2025 and bottomed at $258.7 million in Q1 2024.
- Historically, Assets has averaged $368.4 million across 5 years, with a median of $372.7 million in 2025.
- Annual changes were most pronounced in 2022 — Assets sank 32.54% — and 2025, when it soared 49.5%.
- Rhythm Pharmaceuticals' Assets stood at $382.5 million in 2022, then decreased by 13.0% to $332.7 million in 2023, then gained by 17.89% to $392.3 million in 2024, then climbed by 22.41% to $480.2 million in 2025, then fell by 7.89% to $442.3 million in 2026.
- Business Quant data shows RYTM's Assets at $442.3 million in Q1 2026, $480.2 million in Q4 2025, and $506.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 437.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 437.27 Mn |
| Mar 31, 2026 | 442.32 Mn |
| Dec 31, 2025 | 480.20 Mn |
| Sep 30, 2025 | 506.87 Mn |
| Jun 30, 2025 | 372.73 Mn |
| Mar 31, 2025 | 386.69 Mn |
| Dec 31, 2024 | 392.27 Mn |
| Sep 30, 2024 | 363.57 Mn |
| Jun 30, 2024 | 381.85 Mn |
| Mar 31, 2024 | 258.65 Mn |
| Dec 31, 2023 | 332.75 Mn |
| Sep 30, 2023 | 354.20 Mn |
| Jun 30, 2023 | 309.94 Mn |
| Mar 31, 2023 | 345.68 Mn |
| Dec 31, 2022 | 382.48 Mn |
| Sep 30, 2022 | 389.61 Mn |
| Jun 30, 2022 | 277.68 Mn |
| Mar 31, 2022 | 284.82 Mn |
| Dec 31, 2021 | 329.52 Mn |
| Sep 30, 2021 | 355.82 Mn |